Drugs / KGEL vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00134082 | Nov 2005 → Jan 2013 | lymphoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KGEL vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00134082 ↗ |
| Modality | Vaccine | “an allogeneic vaccine that expresses Hodgkin's tumor antigens” NCT00134082 ↗ |